ArticlePharmaceuticals (Basel, Switzerland)2026
(5R)-5-Hydroxytriptolide (LLDT-8) Ameliorates Experimental Autoimmune Myositis via Suppression of the NLRC5/MHC-I Signaling Pathway.
Tingting Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.